Press Releases

[On-Target] AAV Targeting the Skin — Serotypes, Promoters & Dosages: All You Need in One Guide!
2026-06-26

Skin is the body's largest organ, covering the entire external surface. It serves as a barrier against pathogens, ultraviolet radiation, chemical agents, and mechanical injury, while also sensing external stimuli, regulating temperature, and maintaining hydration. The skin is organized into three principal layers: the epidermis, dermis, and hypodermis.

 

The epidermis is the outermost layer and the body's first line of defense against the external environment. From the surface inward, it is further subdivided into the stratum corneum, stratum lucidum, stratum granulosum, stratum spinosum, and stratum basale. The epidermis itself is avascular, deriving nutrients from the underlying dermis.

 

The dermis is the connective tissue layer immediately beneath the epidermis, comprising a superficial papillary layer and a deeper reticular layer that merge without a distinct boundary. It contains hair follicles, glands, blood vessels, and nerve endings.

 

The hypodermis (subcutaneous tissue) is the deepest skin layer, anchored to the dermis by collagen and elastin fibers. It contains adipose lobules, blood vessels, and nerves, and serves as the body's primary fat storage depot, as well as providing insulation and mechanical cushioning.

Figure 1. Schematic of skin structure (PMID: 29262154)

 

Skin diseases are among the most common and frequently encountered conditions in daily life, and many follow a chronic course. Psoriasis is a chronic inflammatory skin disease characterized by abnormal, rapid, and excessive proliferation of the epidermal keratinocytes, manifesting as well-demarcated or widespread scaly erythematous plaques. Acne vulgaris is another prevalent chronic inflammatory condition arising from follicular occlusion and inflammation, primarily presenting as papules, pustules, and scarring on the face and back; contributing factors include androgen excess, hypersecretion of sebaceous glands, and abnormal follicular keratinization. Vitiligo results from the destruction of epidermal melanocytes, leading to focal melanin deficiency and depigmented macules; its etiology involves autoimmunity, genetic predisposition, and neurochemical factors.

Figure 2. Pathogenesis of psoriasis (PMID: 30909615)

 

Research into these skin conditions frequently requires in vivo experimentation. Recombinant adeno-associated viral vectors (rAAV) have become an essential tool for in vivo gene delivery, valued for their serotype diversity, low immunogenicity, and capacity for long-term stable transgene expression — making them an ideal platform for gene therapy in skin biology.

 

01  AAV Serotype Selection

 

AAV serotypes differ in their capsid proteins and, consequently, in their tropism for specific tissues and cell types. Based on published literature, AAV2, AAV5, AAV7, AAV8, AAV9, and AAVDJ have all been reported to transduce skin tissue. Among these:

 

AAV5 and AAV8 transduce the epidermis with high efficiency and show moderate transduction of the dermis.

AAV9 is widely used for general skin transduction in vivo.

AAVDJ mediates efficient gene delivery across skin layers.

Figure 3. AAV5 and AAV8 transduction of the epidermis and dermis (PMID: 22713157)

Figure 4. Efficient skin transduction by AAVDJ (PMID: 30185909)

 

02  Promoter Selection

 

The skin contains a diverse array of cell types. The epidermis harbors keratinocytes, Langerhans cells, Merkel cells, and melanocytes. Dermal fibroblasts synthesize collagen and elastic fibers. The hypodermis is rich in adipocytes that store energy and provide cushioning. Cell-type-specific promoters enable precise targeting of each population.

 

Keratinocytes

Keratinocytes are the predominant cell type of the epidermis, accounting for approximately 95% of epidermal cells. They originate in the stratum basale, progressively migrate toward the surface as they mature and differentiate, gradually flattening and accumulating keratin, and ultimately desquamate as the stratum corneum to form the skin's protective barrier.

 

• K14 (encoding cytokeratin 14) and BK5 (encoding cytokeratin 5) are expressed specifically in basal layer keratinocytes. Accordingly, the K14 and BK5 promoters selectively target basal keratinocytes.

• K10 (encoding cytokeratin 10) is expressed in suprabasal, post-mitotic keratinocytes undergoing terminal differentiation. The K10 promoter therefore drives expression specifically in differentiating keratinocytes above the basal layer.

 

Melanocytes

Melanocytes reside in the stratum basale of the epidermis, where they synthesize melanin — the primary pigment responsible for skin color — and protect the skin from ultraviolet radiation. The mTyr promoter (mouse tyrosinase promoter) confers melanocyte-specific transgene expression.

Figure 5. Cre recombinase expression driven by the melanocyte-specific mTyr promoter following cutaneous delivery induces melanoma formation (PMID: 31649959)

 

Recommended AAV Serotypes & Promoters for Skin Targeting

 

Target

Promoter

Serotype

Skin

K14 / BK5 : Keratinocytes

AAV9/AAV8/AAVDJ

K10 : Keratinocytes

mTyr : Melanocytes

CBh/CMV/CAG/U6 : Broad infection

Table 1. Recommended AAV serotypes and promoters for skin-targeted gene delivery

 

03  Injection Routes & Dosing

 

The two most commonly used delivery methods for AAV-mediated skin gene transfer are subcutaneous (SC) injection and intradermal (ID) injection. Dosing parameters for each route in adult mice are summarized below.

 

Route

Volume

Dose

Difference

Subcutaneous injection (SC)

~100 μL

1–4E+11 vg

Injected into the subcutaneous tissue

Intradermal injection (ID)

~5–30 μL

~2E+11 vg

Injected between the epidermis and dermis; injection depth 1–2 mm

 

Table 2. Injection routes and dosing guidelines for AAV-mediated skin gene delivery in adult mice

 

04  Application Case Studies

 

Case Study 1 — FGF10 Overexpression Protects Against UVB-Induced Skin Injury

 

CellProliferation, 2022  |  PMID: 35851701

Ultraviolet B (UVB) irradiation induces skin injury by inhibiting keratinocyte proliferation. Fibroblast growth factor 10 (FGF10) is a key keratinocyte mitogen that promotes proliferation and participates in cell cycle regulation, DNA repair, apoptosis, development, and wound healing; however, its role in UVB-induced skin injury had not been established. This study demonstrated that FGF10 expression is elevated in UVB-treated skin, and that FGF10 overexpression protects against UVB-induced skin damage by restoring epidermal thickness and enhancing keratinocyte proliferation. Mechanistically, FGF10 was found to attenuate UVB-mediated suppression of YAP activity, thereby sustaining keratinocyte proliferation. Using AAV-mediated FGF10 overexpression, the investigators showed a reduction in UVB-induced epidermal thickening of the dorsal skin and an increase in proliferating cell nuclear antigen (PCNA) density, collectively confirming a protective role for FGF10 in UVB-induced cutaneous injury. The AAV constructs used in this study were supplied by OBiO Tech.

 

 

 

Parameter

Details

Viral construct

AAV9-Fgf10

Animal model

C57BL/6 mice

Injection route

Subcutaneous injection

Target tissue

Skin

Dosage

1E+11 vg/mouse

Detection time

3 weeks

 

Case Study 2 — Endothelial ACKR1 Drives Immune Cell Infiltration in Skin Fibrosis

 

BritishJournal of Dermatology, 2024  |  PMID: 39009432

Skin fibrosis, characterized by dermal thickening and induration, is the hallmark pathological feature of systemic sclerosis and localized scleroderma; its etiology remains poorly understood and effective therapies are limited. In this study, researchers employed single-cell transcriptomics to construct a cell-type-resolved transcriptional atlas and intercellular communication network of fibrotic skin, providing mechanistic insight into the pathogenesis of skin fibrosis. Their findings revealed that ACKR1 is highly expressed in endothelial cells of fibrotic skin, where it promotes immune cell infiltration; simultaneously, SFRP2/ASPN fibroblasts act in concert to amplify fibrosis. Using AAV constructs produced by OBiO Tech to suppress ACKR1 expression in a bleomycin (BLM) mouse model of skin fibrosis, the team demonstrated a significant reduction in immune cell migration into the dermis and attenuation of fibrosis. The AAV constructs used in this study were produced by OBiO Tech.

 

 

Parameter

Details

Viral construct

AAV-ACKR1

Animal model

C57BL/6 mice

Injection route

Subcutaneous injection

Target tissue

Skin

Dosage

1-3E+11 vg/mouse

Detection time

7 / 21 days

 

References

[1] Yousef H, Alhajj M, Fakoya AO, Sharma S. Anatomy, Skin (Integument), Epidermis.In: StatPearls. StatPearls Publishing; 2024.

[2] Rendon A, Schäkel K. Psoriasis Pathogenesis and Treatment. Int J Mol Sci.2019;20(6):1475.

[3] Keswani SG, et al. Pseudotyped adeno-associated viral vector tropism andtransduction efficiencies in murine wound healing. Wound Repair Regen.2012;20(4):592–600. PMID: 22713157

[4] Kurita M, et al. In vivo reprogramming of wound-resident cells generates skinepithelial tissue. Nature. 2018;561(7722):243–247. PMID: 30185909

[5] Lee LR, et al. Targeting Adeno-Associated Virus Vectors for Local Delivery toFractures and Systemic Delivery to the Skeleton. Mol Ther Methods Clin Dev.2019;15:101–111.

[6] Wang N, et al. Fibroblast growth factor 10 protects against UVB-induced skininjury by activating the ERK/YAP signalling pathway. Cell Prolif.2022;55(11):e13315. PMID: 35851701

[7] Huang Y, et al. Atypical chemokine receptor 1-positive endothelial cellsmediate leucocyte infiltration and synergize with SFRP2/ASPN⁺fibroblasts to promote skin fibrosis in systemic sclerosis. Br J Dermatol.2024;191(6):964–978. PMID:39009432

 

OBiO Tech  |  Scientific Service  |  www.obio-tech.com

Request Now
© OBiO Tech, Inc. All Rights Reserved